Hummingbird Bioscience
Clinical trials sponsored by Hummingbird Bioscience, explained in plain language.
-
New hope for Hard-to-Treat cancers: first human trial launches
Disease control Recruiting nowThis study tests a new drug called HMBD-501 in people with advanced melanoma, lung, or breast cancers that have stopped responding to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors. About 180 adults will take part in two phases: first t…
Phase: PHASE1, PHASE2 • Sponsor: Hummingbird Bioscience • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New hope for advanced cancer patients: drug combo trial opens
Disease control Recruiting nowThis study tests a new drug (HMBD-001) combined with standard treatments (cetuximab, with or without docetaxel) in people with advanced squamous cell cancers of the lung, head and neck, esophagus, cervix, skin, or nasopharynx. The goal is to see if the combination is safe and hel…
Phase: PHASE1, PHASE2 • Sponsor: Hummingbird Bioscience • Aim: Disease control
Last updated May 18, 2026 12:02 UTC